328 related articles for article (PubMed ID: 19648163)
1. Gene polymorphisms in folate metabolizing enzymes in adult acute lymphoblastic leukemia: effects on methotrexate-related toxicity and survival.
Ongaro A; De Mattei M; Della Porta MG; Rigolin G; Ambrosio C; Di Raimondo F; Pellati A; Masieri FF; Caruso A; Catozzi L; Gemmati D
Haematologica; 2009 Oct; 94(10):1391-8. PubMed ID: 19648163
[TBL] [Abstract][Full Text] [Related]
2. Functional variants of gene encoding folate metabolizing enzyme and methotrexate-related toxicity in children with acute lymphoblastic leukemia.
Kałużna E; Strauss E; Zając-Spychała O; Gowin E; Świątek-Kościelna B; Nowak J; Fichna M; Mańkowski P; Januszkiewicz-Lewandowska D
Eur J Pharmacol; 2015 Dec; 769():93-9. PubMed ID: 26528799
[TBL] [Abstract][Full Text] [Related]
3. Folate pathway genetic polymorphisms modulate methotrexate-induced toxicity in childhood acute lymphoblastic leukemia.
Yousef AM; Farhad R; Alshamaseen D; Alsheikh A; Zawiah M; Kadi T
Cancer Chemother Pharmacol; 2019 Apr; 83(4):755-762. PubMed ID: 30684021
[TBL] [Abstract][Full Text] [Related]
4. Influence of folate pathway polymorphisms on high-dose methotrexate-related toxicity and survival in childhood acute lymphoblastic leukemia.
Erčulj N; Kotnik BF; Debeljak M; Jazbec J; Dolžan V
Leuk Lymphoma; 2012 Jun; 53(6):1096-104. PubMed ID: 22074251
[TBL] [Abstract][Full Text] [Related]
5. C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: effect on methotrexate-related toxicity in adult acute lymphoblastic leukaemia.
Eissa DS; Ahmed TM
Blood Coagul Fibrinolysis; 2013 Mar; 24(2):181-8. PubMed ID: 23183238
[TBL] [Abstract][Full Text] [Related]
6. Association of genetic polymorphism in the folate metabolic pathway with methotrexate pharmacokinetics and toxicity in childhood acute lymphoblastic leukaemia and malignant lymphoma.
Faganel Kotnik B; Grabnar I; Bohanec Grabar P; Dolžan V; Jazbec J
Eur J Clin Pharmacol; 2011 Oct; 67(10):993-1006. PubMed ID: 21509569
[TBL] [Abstract][Full Text] [Related]
7. Methylene tetrahydrofolate reductase gene polymorphism in Egyptian children with acute lymphoblastic leukemia.
Tantawy AA; El-Bostany EA; Adly AA; Abou El Asrar M; El-Ghouroury EA; Abdulghaffar EE
Blood Coagul Fibrinolysis; 2010 Jan; 21(1):28-34. PubMed ID: 19923983
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate pharmacogenetics in Uruguayan adults with hematological malignant diseases.
Giletti A; Vital M; Lorenzo M; Cardozo P; Borelli G; Gabus R; Martínez L; Díaz L; Assar R; Rodriguez MN; Esperón P
Eur J Pharm Sci; 2017 Nov; 109():480-485. PubMed ID: 28887233
[TBL] [Abstract][Full Text] [Related]
9. Influence of Folate-Related Gene Polymorphisms on High-Dose Methotrexate-Related Toxicity and Prognosis in Turkish Children with Acute Lymphoblastic Leukemia.
Yazıcıoğlu B; Kaya Z; Güntekin Ergun S; Perçin F; Koçak Ü; Yenicesu İ; Gürsel T
Turk J Haematol; 2017 Jun; 34(2):143-150. PubMed ID: 27094381
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms of 5,10-methylenetetrahydrofolate reductase and thymidylate synthase, dietary folate intake, and the risk of leukemia in adults.
Liu P; Zhang M; Xie X; Jin J; Holman CD
Tumour Biol; 2016 Mar; 37(3):3265-75. PubMed ID: 26438060
[TBL] [Abstract][Full Text] [Related]
11. Folate cycle gene variants and chemotherapy toxicity in pediatric patients with acute lymphoblastic leukemia.
Costea I; Moghrabi A; Laverdiere C; Graziani A; Krajinovic M
Haematologica; 2006 Aug; 91(8):1113-6. PubMed ID: 16870553
[TBL] [Abstract][Full Text] [Related]
12. Impact of methylenetetrahydrofolate reductase (MTHFR) polymorphisms on methotrexate-induced toxicities in acute lymphoblastic leukemia: a meta-analysis.
Yang L; Hu X; Xu L
Tumour Biol; 2012 Oct; 33(5):1445-54. PubMed ID: 22528943
[TBL] [Abstract][Full Text] [Related]
13. Methotrexate toxicity and efficacy during the consolidation phase in paediatric acute lymphoblastic leukaemia and MTHFR polymorphisms as pharmacogenetic determinants.
D'Angelo V; Ramaglia M; Iannotta A; Crisci S; Indolfi P; Francese M; Affinita MC; Pecoraro G; Napolitano A; Fusco C; Oreste M; Indolfi C; Casale F
Cancer Chemother Pharmacol; 2011 Nov; 68(5):1339-46. PubMed ID: 21590445
[TBL] [Abstract][Full Text] [Related]
14. Folate pathway enzyme gene polymorphisms and the efficacy and toxicity of methotrexate in psoriatic arthritis.
Chandran V; Siannis F; Rahman P; Pellett FJ; Farewell VT; Gladman DD
J Rheumatol; 2010 Jul; 37(7):1508-12. PubMed ID: 20472929
[TBL] [Abstract][Full Text] [Related]
15. MTHFR polymorphisms' influence on outcome and toxicity in acute lymphoblastic leukemia patients.
Chiusolo P; Reddiconto G; Farina G; Mannocci A; Fiorini A; Palladino M; La Torre G; Fianchi L; Sorà F; Laurenti L; Leone G; Sica S
Leuk Res; 2007 Dec; 31(12):1669-74. PubMed ID: 17512587
[TBL] [Abstract][Full Text] [Related]
16. Influence of dihydrofolate reductase gene polymorphisms rs408626 (-317A>G) and rs442767 (-680C>A) on the outcome of methotrexate-based maintenance therapy in South Indian patients with acute lymphoblastic leukemia.
Kodidela S; Pradhan SC; Dubashi B; Basu D
Eur J Clin Pharmacol; 2015 Nov; 71(11):1349-58. PubMed ID: 26335211
[TBL] [Abstract][Full Text] [Related]
17. High dose methotrexate treatment in childhood ALL: pilot study on the impact of the MTHFR 677C>T and 1298A>C polymorphisms on MTX-related toxicity.
Haase R; Elsner K; Merkel N; Stiefel M; Mauz-Körholz C; Kramm CM; Körholz D
Klin Padiatr; 2012 Apr; 224(3):156-9. PubMed ID: 22513795
[TBL] [Abstract][Full Text] [Related]
18. Effects of gene polymorphisms on delayed MTX clearance, toxicity, and metabolomic changes after HD-MTX treatment in children with acute lymphoblastic leukemia.
Zhou Y; He H; Ding L; Wang T; Liu X; Zhang M; Zhang A; Fu J
Eur J Pediatr; 2024 Feb; 183(2):581-590. PubMed ID: 37851084
[TBL] [Abstract][Full Text] [Related]
19. Effect of polymorphisms in folate-related genes on in vitro methotrexate sensitivity in pediatric acute lymphoblastic leukemia.
de Jonge R; Hooijberg JH; van Zelst BD; Jansen G; van Zantwijk CH; Kaspers GJ; Peters GJ; Ravindranath Y; Pieters R; Lindemans J
Blood; 2005 Jul; 106(2):717-20. PubMed ID: 15797993
[TBL] [Abstract][Full Text] [Related]
20. Effects of methylenetetrahydrofolate reductase and reduced folate carrier 1 polymorphisms on high-dose methotrexate-induced toxicities in children with acute lymphoblastic leukemia or lymphoma.
Shimasaki N; Mori T; Samejima H; Sato R; Shimada H; Yahagi N; Torii C; Yoshihara H; Tanigawara Y; Takahashi T; Kosaki K
J Pediatr Hematol Oncol; 2006 Feb; 28(2):64-8. PubMed ID: 16462575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
